Cardiovascular Outcomes and Hospitalizations in Asian Patients Receiving Immune Checkpoint Inhibitors: A Population-based Study-Reference-Cited by-同舟云学术

Cardiovascular Outcomes and Hospitalizations in Asian Patients Receiving Immune Checkpoint Inhibitors: A Population-based Study

Published:2023-01 Issue:1 Volume:48 Page:101380
ISSN:0146-2806
Container-title:Current Problems in Cardiology
language:en
Short-container-title:Current Problems in Cardiology

Author:

Chan Jeffrey Shi Kai^ORCID,Lakhani Ishan,Lee Teddy Tai Loy,Chou Oscar Hou In,Lee Yan Hiu Athena,Cheung Yiu Ming,Yeung Hoi Wa,Tang Pias,Ng Kenrick,Dee Edward Christopher,Liu Tong,Wong Wing Tak,Tse Gary^ORCID,Leung Fung Ping

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference30 articles.

1. Immune checkpoint blockade therapy for cancer: an overview of FDA-approved immune checkpoint inhibitors;Hargadon;Int Immunopharmacol,2018

2. ICIs-related cardiotoxicity in different types of cancer;Dong;J Cardiovasc Dev Dis,2022

3. Liver immune-related adverse effects of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors: a propensity score matched study with competing risk analyses;Zhou;Clin Oncol (R Coll Radiol),2022

4. Adverse cardiovascular complications following prescription of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors: a propensity-score matched cohort study with competing risk analysis;Zhou;Cardio-oncology (London, England),2022

5. Immune checkpoint inhibitors and cardiovascular toxicity;Lyon;Lancet Oncol,2018

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-morbid intersections of cancer and cardiovascular disease and targets for natural drug action: Reprogramming of lipid metabolism;Biomedicine & Pharmacotherapy;2024-07

2. Risk factors and outcomes of pericardial effusion in cancer patients receiving PD-1 inhibitors;International Journal of Cardiology;2024-07

3. Cardiovascular adverse events associated with immune checkpoint inhibitors: A retrospective multicenter cohort study;Cancer Medicine;2024-05

4. Prognostic value of cardiovascular magnetic resonance in immune checkpoint inhibitor‐associated myocarditis: A systematic review and meta‐analysis;Cancer Innovation;2024-04-15

5. Immune checkpoints in cardiac physiology and pathology: therapeutic targets for heart failure;Nature Reviews Cardiology;2024-01-26